were harvested at the 6th or 16th week after BMT. Single cell suspensions from
spleens and bone marrows were labeled with anti-CD3 PE, -CD4 FITC, -CD8 AF700
(BD Pharmingen, San Diego, CA, USA) for T cells, anti-CD19 FITC (BD) for B
cells, anti-CXCR3 BV421 and anti-CD80 FITC for immune molecular examination,
anti-CD4 FITC (BD) and anti-Foxp3 PE (eBioscience, San Diego, CA, USA) for
regulatory T cells (Treg), anti-IFN-γ PE and -IL-17A PE-cy7 (BD) for Th1/Th17
subsets, respectively. Before detecting the secretion of IFN-γ and IL-17A in T
cells, cell suspensions were activated with anti-mouse CD3/CD28 microbeads for 3
hours. The spleen mononuclear cells of mice transplanted with A20 lymphoma cells
were stained with anti-B220 PE and -H-2Kb BV421 (eBioscience) to
examine the ratio of tumor cells. Activated human PBMCs with anti- human
CD3/CD28 beads were stained with anti-human CD3 FITC and -CD69 PE for T cell
activation analysis or with anti-human CD4 PE-cy7, -T-bet PE, -Foxp3 AF647,
-GATA3 APC and -ROR?t PE (eBioscience) for T cell differentiation analysis after
incubation with SHR0302 (1 μM) for 24 h. Fixable viability dye or DAPI (BD) were
used to distinguish live cells from dead cells.